Cite
HARVARD Citation
Hartery, K. et al. (2017). Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis. Alimentary pharmacology & therapeutics. 45 (2), pp. 376-378. [Online].